Junhu Zhou

2.9k total citations
62 papers, 2.2k citations indexed

About

Junhu Zhou is a scholar working on Molecular Biology, Cancer Research and Electrical and Electronic Engineering. According to data from OpenAlex, Junhu Zhou has authored 62 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 25 papers in Cancer Research and 14 papers in Electrical and Electronic Engineering. Recurrent topics in Junhu Zhou's work include Cancer-related molecular mechanisms research (12 papers), Glioma Diagnosis and Treatment (11 papers) and MicroRNA in disease regulation (11 papers). Junhu Zhou is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), Glioma Diagnosis and Treatment (11 papers) and MicroRNA in disease regulation (11 papers). Junhu Zhou collaborates with scholars based in China, United States and Portugal. Junhu Zhou's co-authors include Chunsheng Kang, Qixue Wang, Yunfei Wang, Yanli Tan, Kaikai Yi, Chao Yang, Jingxuan Yang, Mingyang Liu, John X. J. Zhang and Jinquan Cai and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Junhu Zhou

61 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junhu Zhou China 26 1.4k 866 386 269 230 62 2.2k
Jun Mi China 27 1.2k 0.9× 809 0.9× 315 0.8× 127 0.5× 53 0.2× 54 2.2k
Yanxiang Deng United States 21 1.3k 1.0× 295 0.3× 638 1.7× 159 0.6× 50 0.2× 41 2.2k
Janine N. Post Netherlands 21 1.1k 0.8× 197 0.2× 489 1.3× 110 0.4× 248 1.1× 66 2.4k
Kaitai Zhang China 24 791 0.6× 465 0.5× 495 1.3× 246 0.9× 38 0.2× 89 2.2k
Carla Lucia Esposito Italy 28 1.7k 1.3× 501 0.6× 348 0.9× 53 0.2× 53 0.2× 62 2.1k
Lu Liu China 29 1.1k 0.8× 508 0.6× 787 2.0× 56 0.2× 109 0.5× 94 2.6k
Katherine S. Yang United States 24 1.5k 1.1× 450 0.5× 783 2.0× 58 0.2× 181 0.8× 48 2.9k
Tae Sup Lee South Korea 24 842 0.6× 236 0.3× 464 1.2× 62 0.2× 54 0.2× 81 2.0k
Kristan E. van der Vos Netherlands 19 1.5k 1.1× 653 0.8× 156 0.4× 77 0.3× 68 0.3× 21 2.1k

Countries citing papers authored by Junhu Zhou

Since Specialization
Citations

This map shows the geographic impact of Junhu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhu Zhou more than expected).

Fields of papers citing papers by Junhu Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhu Zhou. The network helps show where Junhu Zhou may publish in the future.

Co-authorship network of co-authors of Junhu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Junhu Zhou. A scholar is included among the top collaborators of Junhu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhu Zhou. Junhu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Junhu, Xin Qi, & John X. J. Zhang. (2025). Controlled synthesis of metal–insulator–metal nanoparticles for enhanced Raman spectroscopy. Nanoscale. 17(40). 23654–23666. 1 indexed citations
2.
Hong, Biao, Shixue Yang, Xing Cui, et al.. (2025). Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma. Acta Pharmaceutica Sinica B. 15(7). 3632–3645.
3.
Jin, Congran, et al.. (2025). Doped Zinc Oxide‐Based Piezoelectric Devices for Energy Harvesting and Sensing. Advanced Energy and Sustainability Research. 6(9). 4 indexed citations
5.
Cui, Xiaoteng, Jixing Zhao, Guanzhang Li, et al.. (2023). Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma. Cancer Communications. 43(12). 1326–1353. 22 indexed citations
6.
Cui, Xiaoteng, Yunfei Wang, Junhu Zhou, Qixue Wang, & Chunsheng Kang. (2023). Expert opinion on translational research for advanced glioblastoma treatment. Cancer Biology and Medicine. 20(5). 1–9. 13 indexed citations
7.
Zhang, Xiaoyang, Ze-Sheng Li, Cheng Wei, et al.. (2022). PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas. Frontiers in Oncology. 12. 1055371–1055371. 10 indexed citations
8.
Wang, Yunfei, Kaikai Yi, Xing Liu, et al.. (2021). HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas. Frontiers in Immunology. 12. 785463–785463. 31 indexed citations
9.
Chen, Luyue, Junhu Zhou, Qixue Wang, et al.. (2020). TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma. Cancer Biology and Medicine. 17(3). 664–675. 5 indexed citations
10.
Yang, Chao, Yanli Tan, Hongzhao Qi, et al.. (2020). Boosting of the enhanced permeability and retention effect with nanocapsules improves the therapeutic effects of cetuximab. Cancer Biology and Medicine. 17(2). 433–443. 5 indexed citations
11.
Zhou, Junhu, Tong Zhou, Dongsheng Yang, et al.. (2019). Optically Controlled Extraordinary Terahertz Transmission of Bi2Se3 Film Modulator. Photonic Sensors. 9(3). 268–276. 11 indexed citations
12.
Han, Lei, Chaoyong Liu, Hongzhao Qi, et al.. (2019). Systemic Delivery of Monoclonal Antibodies to the Central Nervous System for Brain Tumor Therapy. Advanced Materials. 31(19). e1805697–e1805697. 110 indexed citations
13.
Li, Yansheng, Yu Ren, Yunfei Wang, et al.. (2019). A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep. Theranostics. 9(16). 4608–4623. 84 indexed citations
14.
Shi, Cuijuan, Chun Rao, Cuiyun Sun, et al.. (2018). miR-29s function as tumor suppressors in gliomas by targeting TRAF4 and predict patient prognosis. Cell Death and Disease. 9(11). 1078–1078. 17 indexed citations
15.
Wang, Zengguang, Kai Huang, Yanwei Liu, et al.. (2018). PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma. Cancer Letters. 443. 91–107. 47 indexed citations
16.
Huang, Kai, Chuan Fang, Kaikai Yi, et al.. (2018). The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes. Theranostics. 8(6). 1540–1557. 104 indexed citations
17.
Chen, Qun, Jinquan Cai, Qixue Wang, et al.. (2017). Long Noncoding RNA NEAT1 , Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/ β -Catenin Pathway by Scaffolding EZH2. Clinical Cancer Research. 24(3). 684–695. 265 indexed citations
18.
Yang, Chao, Yansheng Li, Qixue Wang, et al.. (2017). EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells. Cancer Letters. 403. 119–127. 17 indexed citations
19.
Huang, Kai, Chao Yang, Qixue Wang, et al.. (2016). The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells. Cancer Letters. 388. 269–280. 34 indexed citations
20.
Zhou, Junhu. (2006). STUDY ON REACTION THERMODYNAMICS CONCERNING FORMATION OF CALCIUM SULFOALUMINATE——HIGHTEMPERATURE SULFER-FIXATION SUBSTANCE-PHASE. Thermal Power Generation. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026